[1]Kumazawa S, Hamasaka T, Nakayama T, et al.Antioxidant activityof propolis of various geographic origins[J].Food Chemistry, 2004, 84 (3) :329-339.
|
[2]McLennan SV, Bonner J, Milne S, et al.The anti-inflammatoryagent Propolis improves wound healing in a rodent model of experi-mental diabetes[J].Wound Repair Regen, 2008, 16 (5) :706-713.
|
[3]Dota KF, Consolaro ME, Svidzinski TI, et al.Antifungal activity ofBrazilian propolis microparticles against yeasts isolated from vulvo-[vaginal candidiasis[J].Evid Based Complement Alternat Med, 2011.
|
[4]张欣, 党双锁, 程延安.大黄素及黄芪多糖对实验性肝损伤大鼠超微结构的作用[J].西安交通大学学报, 2009, 30 (4) :502-505.
|
[5]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
|
[6]Nieto N, Friedman SL, Cederbaum AI.Paracrine stimulation ofcollagen I protein synthesis by hepatic stellate cells[J].J BiolChem, 2002, 277 (12) :9853-9864.
|
[7]房龙, 杜时雨, 赵洪川, 等.氧应激在大鼠乙醇及四氯化碳致慢性肝损伤中的作用[J].世界华人消化杂志, 2010, 18 (3) :234-239.
|
[8]Mahranl G.The protective effect of aqueous propolis extracton isolatedrathepatocytes against carbon tetrachloride toxicity[J].Drugs Exp ClinRes, 1996, 22 (6) :309-316.
|
[9]孙丽萍, 徐响, 黄少康, 等.蜂胶不同溶剂萃取物组成和抗氧化性的研究[J].食品科学, 2009, 30 (21) :75-78.
|
[10]Ozyurt H, Sgüt S, Yildirim Z, et al.Inhibitory effect of caffeic acidphenethyl ester on bleomycine-induced lung fibrosis in rats[J].Clini-ca Chimica Acta, 2004, 339 (1-2) :65-75.
|
[1] | Ning YANG, Jiang DENG, Yikai WANG, Sha CHANG, Ning GAO, Wenjun WANG, Shuangsuo DANG, Juanjuan SHI. Role and mechanism of caffeic acid phenethyl ester in hepatic stellate cell[J]. Journal of Clinical Hepatology, 2022, 38(10): 2273-2278. doi: 10.3969/j.issn.1001-5256.2022.10.014 |
[2] | Xu JiaMin, Tang YingMei. Current status of research on bile duct lesions and related liver diseases[J]. Journal of Clinical Hepatology, 2019, 35(4): 934-936. doi: 10.3969/j.issn.1001-5256.2019.04.051 |
[3] | Liu Jian, Li Li, Wang XiaoChuan, Zhang ShengNing, Li LaiBang, Mang YuanYi, Gao Yang, Chen YongLin, Ren Gang, Li Wang. Mild hypothermia exerts a protective effect against hepatic ischemia-reperfusion injury in rats by activating the PI3K/Akt signaling pathway[J]. Journal of Clinical Hepatology, 2019, 35(4): 846-851. doi: 10.3969/j.issn.1001-5256.2019.04.027 |
[4] | Wu JunCheng, Xu MingYi. Research advances in the association between exosomes and liver diseases[J]. Journal of Clinical Hepatology, 2017, 33(9): 1815-1819. doi: 10.3969/j.issn.1001-5256.2017.09.042 |
[5] | Wang XiaoMing, Wang YueRen. Application of magnetic resonance imaging in hepatobiliary diseases and related challenges[J]. Journal of Clinical Hepatology, 2016, 32(12): 2231-2235. doi: 10.3969/j.issn.1001-5256.2016.12.002 |
[6] | Hu XianDa, Yue Ying, Wu Peng, Zhou Fei, Luo YuanDai. Research advances in pharmacological effects of Ophiacordyceps sinensis in treatment of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(4): 793-797. doi: 10.3969/j.issn.1001-5256.2016.04.043 |
[7] | Huang LanYu, Xu LieMing. Relationship between liver diseases and autophagy[J]. Journal of Clinical Hepatology, 2014, 30(2): 186-188. doi: 10.3969/j.issn.1001-5256.2014.02.022 |
[8] | Chen Juan, Yin HuaBin. Clinical application of perfusion- weighted MRI in liver diseases[J]. Journal of Clinical Hepatology, 2013, 29(10): 793-796. doi: 10.3969/j.issn.1001-5256.2013.10.018 |
[9] | Zhang Qian, Han Tao. Research progress in advanced oxidation protein products in liver diseases[J]. Journal of Clinical Hepatology, 2013, 29(8): 581-584. doi: 10.3969/j.issn.1001-5256.2013.08.007 |
[10] | Wang JianShe. Development of a robust pediatric hepatology program to improve diagnosis and treatment of liver diseases in children[J]. Journal of Clinical Hepatology, 2012, 28(12): 881-883. |
[11] | Shen MeiRong, Li ZhongPing, Ding XiaoHong, Chu Feng, Hu DeChang. Clinical significance of liver biopsy in diagnosis and treatment of liver disease[J]. Journal of Clinical Hepatology, 2012, 28(7): 545-547. |
[12] | Yang AiTing, Wang BaoEn, You Hong. New evidence of FibroScan′s clinical value for assessing fibrosis, screening liver disease, monitoring chronic liver disease progression, and predicting outcome[J]. Journal of Clinical Hepatology, 2012, 28(9): 644-646. |
[13] | Xu Fang, Liu Jun, Gao PuJun. Severe liver injury with hyperthyroidism : a case report[J]. Journal of Clinical Hepatology, 2011, 27(10): 1096-1098. |
[14] | Liu GuoWang, Cao WuKui. Application of stem cells in liver disease treatment[J]. Journal of Clinical Hepatology, 2011, 27(9): 999-1002. |
[15] | Zheng Shan, Shen Zhen. Pediatric liver transplantation:present and future[J]. Journal of Clinical Hepatology, 2011, 27(7): 722-725. |
[16] | Tian Hui. Advances on the polycystic liver diseases[J]. Journal of Clinical Hepatology, 2011, 27(4): 446-449. |
[17] | Zhang Zhe, Guo JinSheng. The role of high mobility group box 1 in human liver diseases[J]. Journal of Clinical Hepatology, 2011, 27(10): 1116-1120. |
[18] | Gao YanHang. Summary of symposium of translational medicine on liver disease[J]. Journal of Clinical Hepatology, 2011, 27(9): 1008-1009. |
[19] | Bai WenYuan, Liu Na. Prevention and thorough consideration of drug induced liver injury[J]. Journal of Clinical Hepatology, 2011, 27(3): 245-247. |